HighTower Advisors LLC Purchases 81,653 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)

HighTower Advisors LLC boosted its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 199.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 122,587 shares of the company’s stock after acquiring an additional 81,653 shares during the period. HighTower Advisors LLC’s holdings in Takeda Pharmaceutical were worth $1,744,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Cetera Advisors LLC acquired a new position in shares of Takeda Pharmaceutical in the 1st quarter valued at approximately $240,000. Envestnet Portfolio Solutions Inc. increased its holdings in Takeda Pharmaceutical by 15.9% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 29,870 shares of the company’s stock worth $387,000 after purchasing an additional 4,107 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Takeda Pharmaceutical by 74.0% in the 2nd quarter. Blue Trust Inc. now owns 5,480 shares of the company’s stock valued at $76,000 after purchasing an additional 2,330 shares during the period. Raymond James & Associates lifted its holdings in shares of Takeda Pharmaceutical by 5.3% in the second quarter. Raymond James & Associates now owns 255,762 shares of the company’s stock valued at $3,310,000 after purchasing an additional 12,862 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of Takeda Pharmaceutical by 40.5% in the second quarter. Allspring Global Investments Holdings LLC now owns 10,907 shares of the company’s stock valued at $141,000 after purchasing an additional 3,143 shares in the last quarter. 9.17% of the stock is owned by institutional investors and hedge funds.

Takeda Pharmaceutical Stock Down 0.2 %

NYSE:TAK opened at $13.42 on Friday. The stock has a 50-day simple moving average of $13.81 and a 200 day simple moving average of $13.88. Takeda Pharmaceutical Company Limited has a 52-week low of $12.57 and a 52-week high of $15.08. The company has a market cap of $42.70 billion, a PE ratio of 23.14, a PEG ratio of 0.25 and a beta of 0.51. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.77 and a current ratio of 1.28.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.